RESUMEN
This study evaluates the effectiveness of immunomodulating drug isoprinosine in a comprehensive treatment of genital warts in men. Most of the patients were aged 20-30 years. The combination therapy was found to have long term effectiveness. In the group of patients undergoing only destructive methods of treatment relapse after 8 month follow-up was diagnosed in 32% and in patients of the combination therapy group (destruction plus isoprinosine) - in 7% of patients. The pharmacological action of the drug (immunostimulating, antiviral) and the effectiveness of its combination with destructive therapies justify the use of inosine pranobex (isoprinosine) both in the complex therapy of genital warts and for the prevention of the disease recurrence.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Antivirales/uso terapéutico , Condiloma Acuminado/tratamiento farmacológico , Enfermedades de los Genitales Masculinos/tratamiento farmacológico , Inosina Pranobex/uso terapéutico , Infecciones por Papillomavirus/tratamiento farmacológico , Adyuvantes Inmunológicos/administración & dosificación , Adyuvantes Inmunológicos/efectos adversos , Adulto , Antivirales/administración & dosificación , Antivirales/efectos adversos , Terapia Combinada , Condiloma Acuminado/inmunología , Condiloma Acuminado/cirugía , Condiloma Acuminado/virología , Quimioterapia Combinada , Enfermedades de los Genitales Masculinos/inmunología , Enfermedades de los Genitales Masculinos/cirugía , Enfermedades de los Genitales Masculinos/virología , Humanos , Inosina Pranobex/administración & dosificación , Inosina Pranobex/efectos adversos , Masculino , Infecciones por Papillomavirus/inmunología , Infecciones por Papillomavirus/cirugía , Infecciones por Papillomavirus/virología , Resultado del Tratamiento , Adulto JovenRESUMEN
The aim of the study was to assess the effect of a combined preparation of Vitaprost on blood supply and microcirculation in the prostate gland in 35 patients with chronic infectious urethral prostatitis. The effectiveness of treatment was estimated by a combination of clinical, bacteriological and instrumental diagnostic methods. Transrectal ultrasonography with color Doppler and laser Doppler flowmetry were used to estimate all components of blood circulation in the prostate. Examination results obtained before and after treatment showed better clinical outcomes and improved parameters of blood flow and microcirculation in the prostate in patients receiving Vitapost. These results indicate that combination therapy including Vitaprost is effective in correcting blood flow and microcirculatory disorders of the prostate and can be utilized in the treatment of chronic infectious urethral prostatitis.